Skip to main content

Peer Review reports

From: Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: a retrospective analysis

Original Submission
27 Sep 2021 Submitted Original manuscript
15 Nov 2021 Reviewed Reviewer Report
24 Nov 2021 Reviewed Reviewer Report - Zhanjun Hou
26 Nov 2021 Author responded Author comments - Jin Suminokura
Resubmission - Version 2
26 Nov 2021 Submitted Manuscript version 2
1 Feb 2022 Author responded Author comments - Jin Suminokura
Resubmission - Version 3
1 Feb 2022 Submitted Manuscript version 3
Publishing
7 Feb 2022 Editorially accepted
16 Feb 2022 Article published 10.1186/s12885-022-09271-3

You can find further information about peer review here.

Back to article page